Cytori Therapeutics, Inc. (CYTX)

[JJAAMMAANN]

Cytori Therapeutics jumps as Maxim sees it as takeover candidate

Jason AycockJan. 5, 2018 6:42 PM ET
Nanocap Cytori Therapeutics (NASDAQ:CYTX) vaulted in the last 15 minutes of the week's trading to a 74% gain after it was floated as a likely acquisition candidate by Maxim.

Analyst Jason Kolbert sees Takeda's (OTCPK:TKPYY) play for Tigenix (NASDAQ:TIG) as a positive sign for Cytori, since it makes a similar adipose-based product for regenerative medicine.

He has a price target of $5 vs. today's close of $0.47.

Volume was about 7.7M shares today vs. an average of less than 1M. Shares have drawn back slightly postmarket, -13%.

Source: Bloomberg

Basically Maxim reporter stated that CYTX would be a good Buyout Candidate seeing as Tigenix was made a significant offer from a Japanese company today. He said Cytori has just as much of a chance based on their research....and assigned a new price target.
I doubt a buyout will happen in the near future, but admit anything can happen!
Best of luck!